All Posts: cancer research
-
Sharing Innovation and Motivation at the Ruesch Center Symposium
Nearly 300 medical professionals, patients, caregivers and advocates attended the 8th Annual Ruesch Center Symposium on December 1, listening to lectures on topics including precision medicine, immunotherapy, proton therapy and molecular imaging.
Category: GUMC Stories
-
New Test Provides Accurate Measure of DNA Damage from Chemical Compounds
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
Category: News Release
-
Schlegel Strives to Create Another Cervical Cancer Game Changer
While the HPV vaccine has been a game changer, recent research by Richard Schlegel, MD, PhD, may lead to another advance by treating women already infected with HPV and a precancerous condition that often leads to the development of cervical cancer.
Category: GUMC Stories
-
By Decoding How HPV Causes Cancer, Researchers Find a New Potential Treatment Strategy
A study that teases apart the biological mechanisms by which human papillomaviruses (HPV) cause cancer has found what researchers at Georgetown University Medical Center say is a new strategy that might provide targeted treatment for these cancers.
Category: News Release
-
Two Agents Deliver Knockout Punches to Ewing Sarcoma
When combined with an already FDA-approved chemotherapy, a novel agent developed by researchers at Georgetown University Medical Center appears to halt the ability of Ewing sarcoma to grow and progress.
Category: News Release
-
Precision Medicine and Immunotherapy: Tomorrow's Cancer Treatments Today at Georgetown Lombardi
Diane Lucey’s unusual cancer stumped her doctors. But after ordering a profile of her tumor, medical oncologist Louis Weiner knew exactly how to proceed.
Category: GUMC Stories
-
Scientists Describe Lab Technique With Potential To Change Medicine and Research
Researchers who developed and tested a revolutionary laboratory technique that allows for the endless growth of normal and diseased cells in a laboratory are publicly sharing how the technique works.
Category: News Release
-
Study Tests New Breast Cancer Drug in African American Women
WASHINGTON — The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling patients at six institutions in Washington, DC, Maryland, Alabama and New Jersey.
Category: News Release
-
In Mice, Daughters of Overweight Dads Have Altered Breast Tissue, Higher Cancer Risk
WASHINGTON — Obese male mice and normal weight female mice produce female pups that are overweight at birth through childhood, and have delayed development of their breast tissue as well as increased rates of breast cancer.
Category: News Release
-
10-Minute Urine Test Can Measure Specific Compounds from Food Consumed
Researchers at Georgetown Lombardi Comprehensive Cancer Center in Washington, DC, have developed a method that can quickly evaluate specific food compounds in human urine. They say their method could one day replace unreliable food logs used in population studies examining the effects of diet on cancer and will also help scientists accurately identify the most beneficial anticancer foods.
Category: News Release